Erlotinib [clinicaltrials_resource:fadaee21143ce80b9b918d5972257fa2]
The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer [clinicaltrials:NCT01000428]Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer [clinicaltrials:NCT01130753]Combination of Chemotherapy and Gefitinib as First-line Treatment of Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomised Controlled Trial [clinicaltrials:NCT02148380]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
clinicaltrials:NCT00026338Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00030446]Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer [clinicaltrials:NCT00030485]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT00030537]clinicaltrials:NCT00030576Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix [clinicaltrials:NCT00031993]Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00032110]Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [clinicaltrials:NCT00032123]Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors [clinicaltrials:NCT00033241]Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer [clinicaltrials:NCT00033462]clinicaltrials:NCT00033514OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00036647]Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung [clinicaltrials:NCT00039182]Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [clinicaltrials:NCT00039494]OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. [clinicaltrials:NCT00040183]Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00042809]Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [clinicaltrials:NCT00042835]clinicaltrials:NCT00043823Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00045201]clinicaltrials:NCT00045487Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [clinicaltrials:NCT00045526]Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed [clinicaltrials:NCT00047333]Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction [clinicaltrials:NCT00047346]A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer [clinicaltrials:NCT00047736]Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer [clinicaltrials:NCT00047762]Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00049101]Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer [clinicaltrials:NCT00049166]Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [clinicaltrials:NCT00049283]Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer [clinicaltrials:NCT00054132]clinicaltrials:NCT00054275Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme [clinicaltrials:NCT00054496]Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [clinicaltrials:NCT00055770]Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00055913]Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00059787]clinicaltrials:NCT00059852Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer [clinicaltrials:NCT00060307]A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00060411]Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00062101]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Erlotinib [clinicaltrials_resource:fadaee21143ce80b9b918d5972257fa2]
Bio2RDF identifier
fadaee21143ce80b9b918d5972257fa2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fadaee21143ce80b9b918d5972257fa2
identifier
clinicaltrials_resource:fadaee21143ce80b9b918d5972257fa2
title
Erlotinib
@en
type
label
Erlotinib [clinicaltrials_resource:fadaee21143ce80b9b918d5972257fa2]
@en